Home / Business and Economy / Lilly Expands into Women's Health
Lilly Expands into Women's Health
10 Sep
Summary
- Lilly made a $40 million investment in Absci Corp.
- Absci Corp. is developing an endometriosis treatment.
- Lilly is building expertise in women's health.
Eli Lilly & Co. is actively expanding its strategic focus on women's health. This initiative involves significant investments and a commitment to developing new treatments in this underserved area.
Recently, Lilly made a $40 million strategic investment in Absci Corp. This investment is geared towards advancing Absci's development of an experimental treatment specifically for endometriosis.
The pharmaceutical giant is concurrently assembling a dedicated team of experts. This effort aims to build comprehensive capabilities and leadership within the women's health sector, indicating a serious and sustained commitment to the field.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
